Literature DB >> 14586000

Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues.

Anneleen Janssen1, Pierre Gressens, Markus Grabenbauer, Eveline Baumgart, Arno Schad, Ilse Vanhorebeek, Annelies Brouwers, Peter E Declercq, Dariush Fahimi, Philippe Evrard, Luc Schoonjans, Désiré Collen, Peter Carmeliet, Guy Mannaerts, Paul Van Veldhoven, Myriam Baes.   

Abstract

Functional peroxisome deficiency, as encountered in Zellweger syndrome, causes a specific impairment of neuronal migration. Although the molecular mechanisms underlying the neuronal migration defect are at present unknown, the excess of very long chain fatty acids in brain, a consequence of peroxisomalbeta-oxidation deficiency, has often been hypothesized to play a major role. The purpose of the present study was to investigate the contribution of peroxisomal dysfunction in brain as opposed to peroxisomal dysfunction in extraneuronal tissues to the migration defect. Peroxisomes were selectively reconstituted either in brain or liver of Pex5 knock-out mice, a model for Zellweger syndrome, by tissue-selective overexpression of Pex5p. We found that both rescue strains exhibited a significant correction of the neuronal migration defect despite an incomplete reconstitution of peroxisomal function in the targeted tissue. Animals with a simultaneous rescue of peroxisomes in both tissues displayed a pattern of neuronal migration indistinguishable from that of wild-type animals on the basis of cresyl violet staining and 5',3'-bromo-2'-deoxyuridine birth-dating analysis. These data suggest that peroxisomal metabolism in brain but also in extraneuronal tissues affects the normal development of the mouse neocortex. In liver-rescued mice, the improvement of the neuronal migration was not accompanied by changes in very long chain fatty acid, docosahexaenoic acid, or plasmalogen levels in brain, indicating that other metabolic factors can influence the neuronal migration process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586000      PMCID: PMC6740889     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

Review 1.  Genetic malformations of the human cerebral cortex.

Authors:  C A Walsh
Journal:  Neuron       Date:  1999-05       Impact factor: 17.173

Review 2.  Central nervous system neuronal migration.

Authors:  M E Hatten
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

Review 3.  Mechanisms and disturbances of neuronal migration.

Authors:  P Gressens
Journal:  Pediatr Res       Date:  2000-12       Impact factor: 3.756

4.  Visualization of neurogenesis in the central nervous system using nestin promoter-GFP transgenic mice.

Authors:  M Yamaguchi; H Saito; M Suzuki; K Mori
Journal:  Neuroreport       Date:  2000-06-26       Impact factor: 1.837

Review 5.  Import of peroxisomal matrix and membrane proteins.

Authors:  S Subramani; A Koller; W B Snyder
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

6.  Docosahexaenoic acid deficit is not a major pathogenic factor in peroxisome-deficient mice.

Authors:  A Janssen; M Baes; P Gressens; G P Mannaerts; P Declercq; P P Van Veldhoven
Journal:  Lab Invest       Date:  2000-01       Impact factor: 5.662

7.  Detection of peroxisomal proteins and their mRNAs in serial sections of fetal and newborn mouse organs.

Authors:  M Grabenbauer; H D Fahimi; E Baumgart
Journal:  J Histochem Cytochem       Date:  2001-02       Impact factor: 2.479

8.  Neuronal migration disorder in Zellweger mice is secondary to glutamate receptor dysfunction.

Authors:  P Gressens; M Baes; P Leroux; A Lombet; P Van Veldhoven; A Janssen; J Vamecq; S Marret; P Evrard
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

9.  Chicken beta-globin 5'HS4 insulators function to reduce variability in transgenic founder mice.

Authors:  W Potts; D Tucker; H Wood; C Martin
Journal:  Biochem Biophys Res Commun       Date:  2000-07-14       Impact factor: 3.575

10.  Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse.

Authors:  S Huyghe; M Casteels; A Janssen; L Meulders; G P Mannaerts; P E Declercq; P P Van Veldhoven; M Baes
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

View more
  12 in total

1.  Lipidomics unveils lipid dyshomeostasis and low circulating plasmalogens as biomarkers in a monogenic mitochondrial disorder.

Authors:  Matthieu Ruiz; Alexanne Cuillerier; Caroline Daneault; Sonia Deschênes; Isabelle Robillard Frayne; Bertrand Bouchard; Anik Forest; Julie Thompson Legault; Frederic M Vaz; John D Rioux; Yan Burelle; Christine Des Rosiers
Journal:  JCI Insight       Date:  2019-07-25

Review 2.  Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease.

Authors:  Giuseppe Astarita; Daniele Piomelli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-05-04       Impact factor: 4.006

3.  Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum.

Authors:  Andre Teigler; Dorde Komljenovic; Andreas Draguhn; Karin Gorgas; Wilhelm W Just
Journal:  Hum Mol Genet       Date:  2009-03-08       Impact factor: 6.150

4.  Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients.

Authors:  S Weller; H Rosewich; J Gärtner
Journal:  J Inherit Metab Dis       Date:  2008-04-14       Impact factor: 4.982

5.  PEX13 deficiency in mouse brain as a model of Zellweger syndrome: abnormal cerebellum formation, reactive gliosis and oxidative stress.

Authors:  C Catharina Müller; Tam H Nguyen; Barbara Ahlemeyer; Mallika Meshram; Nishreen Santrampurwala; Siyu Cao; Peter Sharp; Pamela B Fietz; Eveline Baumgart-Vogt; Denis I Crane
Journal:  Dis Model Mech       Date:  2010-10-19       Impact factor: 5.758

6.  Pathogenesis of peroxisomal deficiency disorders (Zellweger syndrome) may be mediated by misregulation of the GABAergic system via the diazepam binding inhibitor.

Authors:  Rainer Breitling
Journal:  BMC Pediatr       Date:  2004-03-12       Impact factor: 2.125

Review 7.  Peroxisomes in brain development and function.

Authors:  Johannes Berger; Fabian Dorninger; Sonja Forss-Petter; Markus Kunze
Journal:  Biochim Biophys Acta       Date:  2015-12-11

8.  Long-Term Cholic Acid Therapy in Zellweger Spectrum Disorders.

Authors:  James E Heubi; Kenneth D R Setchell; Kevin E Bove
Journal:  Case Rep Gastroenterol       Date:  2018-06-28

9.  The peroxisome: still a mysterious organelle.

Authors:  Michael Schrader; H Dariush Fahimi
Journal:  Histochem Cell Biol       Date:  2008-02-15       Impact factor: 4.304

10.  Molecular cloning, gene structure and expression profile of two mouse peroxisomal 3-ketoacyl-CoA thiolase genes.

Authors:  Grégory Chevillard; Marie-Claude Clémencet; Philippe Etienne; Pascal Martin; Thierry Pineau; Norbert Latruffe; Valérie Nicolas-Francès
Journal:  BMC Biochem       Date:  2004-03-25       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.